These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 20478861

  • 1. Modification of myocardial substrate utilisation: a new therapeutic paradigm in cardiovascular disease.
    Beadle RM, Frenneaux M.
    Heart; 2010 Jun; 96(11):824-30. PubMed ID: 20478861
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of free fatty acids metabolism as a therapeutic target in patients with heart failure.
    Fragasso G.
    Int J Clin Pract; 2007 Apr; 61(4):603-10. PubMed ID: 17394434
    [Abstract] [Full Text] [Related]

  • 3. Energetic myocardial metabolism and oxidative stress: let's make them our friends in the fight against heart failure.
    Scolletta S, Biagioli B.
    Biomed Pharmacother; 2010 Mar; 64(3):203-7. PubMed ID: 19954925
    [Abstract] [Full Text] [Related]

  • 4. Anti-anginal effects of partial fatty acid oxidation inhibitors.
    Lam A, Lopaschuk GD.
    Curr Opin Pharmacol; 2007 Apr; 7(2):179-85. PubMed ID: 17307396
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Metabolic therapy for the treatment of ischemic heart disease: reality and expectations.
    Wang W, Lopaschuk GD.
    Expert Rev Cardiovasc Ther; 2007 Nov; 5(6):1123-34. PubMed ID: 18035928
    [Abstract] [Full Text] [Related]

  • 7. Metabolic remodelling of the failing heart: beneficial or detrimental?
    van Bilsen M, van Nieuwenhoven FA, van der Vusse GJ.
    Cardiovasc Res; 2009 Feb 15; 81(3):420-8. PubMed ID: 18854380
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Competition between lactate and fatty acids as sources of ATP in the isolated working rat heart.
    Schönekess BO.
    J Mol Cell Cardiol; 1997 Oct 15; 29(10):2725-33. PubMed ID: 9344767
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Metabolic toxicity of the heart: insights from molecular imaging.
    Iozzo P.
    Nutr Metab Cardiovasc Dis; 2010 Mar 15; 20(3):147-56. PubMed ID: 20031381
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Optimizing cardiac energy metabolism: how can fatty acid and carbohydrate metabolism be manipulated?
    Lopaschuk GD.
    Coron Artery Dis; 2001 Feb 15; 12 Suppl 1():S8-11. PubMed ID: 11286307
    [Abstract] [Full Text] [Related]

  • 14. Energy metabolism in the ischemic heart.
    Rovetto MJ.
    Tex Rep Biol Med; 1979 Feb 15; 39():397-407. PubMed ID: 553321
    [Abstract] [Full Text] [Related]

  • 15. Decreased rates of substrate oxidation ex vivo predict the onset of heart failure and contractile dysfunction in rats with pressure overload.
    Doenst T, Pytel G, Schrepper A, Amorim P, Färber G, Shingu Y, Mohr FW, Schwarzer M.
    Cardiovasc Res; 2010 Jun 01; 86(3):461-70. PubMed ID: 20035032
    [Abstract] [Full Text] [Related]

  • 16. A novel partial fatty acid oxidation inhibitor decreases myocardial oxygen consumption and improves cardiac efficiency in demand-induced ischemic heart.
    Wu L, Belardinelli L, Fraser H.
    J Cardiovasc Pharmacol; 2008 Apr 01; 51(4):372-9. PubMed ID: 18427280
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Demand-induced ischemia in volume expanded isolated rat heart; the effect of dichloroacetate and trimetazidine.
    Skierczynska A, Beresewicz A.
    J Physiol Pharmacol; 2010 Apr 01; 61(2):153-62. PubMed ID: 20436215
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.